New York City, NY -- (SBWIRE) -- 01/31/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Concur Technologies, Inc. (NASDAQ:CNQR), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Facebook Inc (NASDAQ:FB), ServiceNow Inc (NYSE:NOW)
Concur Technologies, Inc. (NASDAQ:CNQR) gained 17.08%, trading on 3.00 million shares, to end the trade at $127.45. The stock changed hands in a range of $117.30 to $130.39, bringing its market capitalization to about $7.15 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $62.01 and was moved to the maximum level of $130.39. Concur Technologies, Inc. (Concur) is a global provider of on-demand Employee Spend Management solutions. The Company’s software solutions enable organizations to control costs by automating the processes used to manage employee spending. Its solutions unite online travel procurement with automated expense reporting and optimize the process of collecting, submitting, tracking and paying supplier invoices and check requests.
For How Long CNQR Gloss will Attract Investors? Find out via this report
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) added 15.56%, to complete the trading session at $5.20, with a total volume of 6.23 million shares. The stock, on average, trades on a volume of 1.42 million shares. It floated in a range of $4.26 to $5.45 during the last trading session, with a beta value of 1.24. Its market capitalization now moved to about $316.29 million. In the past 52 weeks, the share price has not declined below $2.53 and above $7.45. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways in the growth of aggressive cancers. In gastroenterology, its first commercial product is RELISTOR subcutaneous injection.
Will PGNX Continue To Move Higher? Find Out Here
Facebook Inc (NASDAQ:FB) recorded a gain of 14.10% and was in a range of $60.46-$62.50 before closing at $61.08. The stock completed the day with a total volume of 150.44 million shares, versus an average volume of 66.84 million shares. The share price hit its 52-week low of $22.67 and $62.50 was the best price. Facebook, Inc. (Facebook) is engaged in building products to create utility for users, developers, and advertisers. People use Facebook to stay connected with their friends and family, to discover what is going on in the world around them, and to share and express what matters to them to the people they care about.
Why Should Investors Buy FB After The Recent Gain? Just Go Here and Find Out
ServiceNow Inc (NYSE:NOW) added 13.91% yesterday, bringing its market capitalization around $9.10 billion. The share price, after opening at $68.45, made a high of $70.48 and hovered above $65.27 to end the day at $65.61. The total number of shares that changed hands during the session was 6.92 million shares, as compared to average trading volume of 1.38 million shares. ServiceNow, Inc. is a provider of cloud-based services to automate enterprise information technology (IT) operations. The Company’s service includes a suite of applications built on its platform that automates workflow and integrates related business processes.
What was the Moving Force behind NOW on Bullish Run? Read This Research Report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)